Actively Recruiting

All Genders
NCT05826444

Microvascular Cardiac Allograft Vasculopathy Trial

Led by German Heart Institute · Updated on 2024-08-12

50

Participants Needed

1

Research Sites

169 weeks

Total Duration

On this page

Sponsors

G

German Heart Institute

Lead Sponsor

D

Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of the mCAV study is a comprehensive characterization of the genetic, morphological and functional phenotype of isolated microvascular graft vasculopathy (mCAV) after orthotopic heart transplantation (OHT). The utilized methods include dynamic echocardiography, magnetic resonance imaging, invasive microvascular resistance measurements, histology, cellular calcium-signaling and magnetocardiography as well as molecular genetic expression analysis (miRNA based).

CONDITIONS

Official Title

Microvascular Cardiac Allograft Vasculopathy Trial

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Able to consent
  • Written consent provided after explanation and consideration
  • Heart transplant recipient
  • Indication for routine invasive diagnostics or symptoms
  • Exercise tolerance in daily life (cycling, climbing at least 2 floors at moderate speed without symptoms)
Not Eligible

You will not qualify if you...

  • Addiction or diseases preventing understanding of the study
  • Inability to provide or understand written consent due to language barriers
  • Pregnant or breastfeeding women
  • Severe comorbidities affecting miRNA profile: diabetes mellitus, malignancy, end-stage renal disease with renal replacement therapy
  • Contraindications to stress test including cardiac decompensation, angina, dyspnea, hyperthyroidism, GFR <30 ml/min, peripheral arterial disease, pheochromocytoma, angle-closure glaucoma, prostate adenoma, paroxysmal tachycardia, atrial fibrillation
  • Evidence of acute rejection or local wall motion disturbances on resting echocardiography

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

DHZC Deutsches Herzzentrum der Charité

Berlin, Germany, 13353

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here